Two lawsuits challenge the $1.8B Anti-Weaponization Fund's legality, citing the 14th Amendment and APA. A court injunction could block Treasury from funding payouts by July 20.
Two lawsuits filed within a week of the Trump administration's announcement of a nearly $1.8 billion Anti-Weaponization Fund now threaten to freeze the payment pipeline before a single dollar reaches intended recipients. The fund, ordered by President Donald Trump as part of a settlement to drop his $10 billion lawsuit against the IRS, would pay out to what the administration calls "victims of lawfare and weaponization" – a category that includes individuals charged in connection with the January 6 Capitol riot.
Both lawsuits argue the mechanism is unconstitutional, bypasses congressional oversight, and violates the Administrative Procedure Act (APA). For traders and macro investors tracking political risk, the fund's legal survival is a test of executive authority over federal spending and a potential precedent for future settlement-driven payouts.
The Public Integrity Project, founded by former DOJ special counsel Brendan Ballou, filed the first lawsuit last week. Democracy Forward, a D.C.-based nonprofit, followed on Friday. Both groups allege the fund is a "slush fund" that lacks a legitimate legal basis. The lawsuits name as plaintiffs Metropolitan Police officer Daniel Hodges and former U.S. Capitol Police officer Harry Dunn (Public Integrity Project), and former Assistant U.S. Attorney Andrew Floyd and the National Abortion Federation (Democracy Forward).
The Public Integrity Project's suit specifically invokes Section 3 of the 14th Amendment, which bars the government from using federal money to pay debts "incurred in aid of insurrection or rebellion against the United States." Ballou said the fund would pay the very rioters who threatened his clients – officers who defended the Capitol on January 6 and continue to receive death threats from supporters of those rioters.
Democracy Forward's lawsuit focuses on the fund's structure. It alleges the fund "exceeds executive authority, unlawfully bypasses Congress's exclusive authority over federal spending and appropriations and violates the Administrative Procedure Act." The APA requires that federal agencies follow specific rulemaking and adjudication procedures. The fund, the suit argues, contains no mechanism for judicial review, no clear criteria for who can file claims, no process for determining payout amounts, and explicitly sidesteps congressional oversight.
Ballou, speaking to UPI, described the fundamental contradiction:
President Trump ordered the fund's creation as part of a settlement agreement to drop his $10 billion lawsuit against the IRS – a suit brought by Trump and his sons Donald Jr. and Eric over the alleged leak of Trump's tax returns during his first term. The U.S. Treasury Department is directed to fill the fund within 60 days using tax dollars. The DOJ spokesperson told UPI that anyone who believes they were a victim of lawfare can submit a claim, and a commission will decide who receives what.
The DOJ has offered no timeline for the commission's formation, no published eligibility standards, and no appeals process. The APA requires that agencies provide notice-and-comment rulemaking for new payment programs of this scale. Bypassing that process invites court injunctions. The Trump administration has already faced similar APA challenges over changes to FEMA grant policy, EPA grant policy, and the renaming of the John F. Kennedy Center for the Performing Arts.
The risk is not confined to the fund's direct beneficiaries. Three groups face concrete exposure:
A successful legal block would reinforce the principle that Congress holds the power of the purse. That would limit the ability of any administration – Democratic or Republican – to create similar off-budget settlement funds. For investors in Treasury bonds, the fund's size ($1.8B) is negligible relative to the $27 trillion+ debt market. The precedent of executive unilateral spending – if upheld – could gradually erode fiscal discipline over time. That is a longer-term macro risk, not a near-term bond-pricing factor.
The Treasury is required to fill the fund within 60 days of the May 21 announcement. That puts the deadline around July 20, 2025. The lawsuits are still in early stages:
A temporary restraining order or preliminary injunction is the most likely near-term catalyst. If either court issues a TRO, the Treasury would be barred from transferring funds until a full hearing. If no injunction is granted, the fund could be funded by late July, and payout claims could start soon after. That would shift the risk from blocking the fund to challenging individual payouts.
This is not an isolated legal battle. The Trump administration has repeatedly bypassed APA rulemaking procedures in other domains. The fund's legal outcome may signal how courts will treat future executive actions that attempt to spend money or create entitlements without congressional approval. Five agencies have been challenged under similar APA theories this year alone:
If the courts uphold the fund despite the APA arguments, it would weaken the APA as a check on executive spending. That would have implications for any administration seeking to bypass normal appropriations. For hedge funds and macro desks that track regulatory risk, this case is a watch item – not for immediate trade, for the regime shift it represents.
The Anti-Weaponization Fund faces a steep uphill legal climb. The two lawsuits exploit a clear structural weakness: settling a case that no longer exists, funding it without congressional approval, and offering no procedural protections. Whether that yields an injunction or a drawn-out merits fight will determine if $1.8 billion flows to January 6 defendants – or becomes a cautionary note in constitutional law textbooks.
Prepared with AlphaScala research tooling and grounded in primary market data: live prices, fundamentals, SEC filings, hedge-fund holdings, and insider activity. Each story is checked against AlphaScala publishing rules before release. Educational coverage, not personalized advice.